Trial Profile
A Phase Ia trial comparing the safety and immunogenicity of BK-SE36 and BK-SE36/CpG in Japanese naive adults.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 20 Sep 2016
Price :
$35
*
At a glance
- Drugs Malaria vaccine (Primary)
- Indications Malaria
- Focus Adverse reactions; Therapeutic Use
- 20 Sep 2016 New trial record